1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE SERVICES
  4. PRECIPIO INC

Precipio Inc XNAS: PRPO

Precipio Inc Live Share Price Today, Share Analysis and Chart

Download real time

6.09 0.44 (7.79%)

43.30% Fall from 52W High

260 XNAS Volume

XNAS 02 Apr, 2025 10:37 AM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The latest board meeting for Precipio Inc took place on 01 Apr 2025, for the purpose of Precipio Inc Fourth Quarter Earnings Results for 2024 See details

Precipio Inc Key Metrics

Default

Market Capitalization

Low in industry
9

PE TTM

Negative PE TTM
-3

Price to Book

Below industry Median
0.7

Institutional holding current Qtr %

Low in industry
5

Revenue Growth Qtr YoY %

Below industry Median
15.3

Operating Revenue growth TTM %

High in industry
31.3

Net Profit Qtr Growth YoY %

Below industry Median
57

Net Profit TTM Growth %

Below industry Median
66.9

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-11.5

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-27.2

Piotroski Score

Below industry Median
3

Rel Perf vs Sector quarter%

9.7

ROE Annual %

Negative ROE Annual %
-38.1

RoA Annual %

Negative RoA Annual %
-29.6
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
25.8 / 100
Momentum Score
Technically Neutral
42.3 / 100
Analyst Price Target
No estimates available

16

S

5

W

1

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Precipio Inc Live Price Chart

Switch to TradingView
Fetching data ...

Precipio Inc Stock Analysis

Precipio Inc stock analysis with key metrics, changes, and trends.

Precipio Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$15.2 M14.62%positive

Annual Revenue rose 14.62%, in the last year to $15.2 M. Its sector's average revenue growth for the last fiscal year was 8.14%.

Annual Net Profit$5.85 M35.45%positive

Annual Net Profit rose 35.45% in the last year to $5.85 M. Its sector's average net profit growth for the last fiscal year was 3.3%.

Price to Earning Ratio-3.01-negative

Price to Earning Ratio is -3.01, which is negative.

Stock Price$6.09-10.96%negative

Stock Price fell 10.96% and underperformed its sector by 13.85% in the past year.

Quarterly Revenue$5.21 M15.29%positive

Quarterly Revenue rose 15.29% YoY to $5.21 M. Its sector's average revenue growth YoY for the quarter was 9.56%.

Quarterly Net profit$0.63 M56.98%positive

Quarterly Net profit rose 56.98% YoY to $0.63 M. Its sector's average net profit growth YoY for the quarter was 35.43%.

Debt to Equity Ratio0.08-positive

Debt to Equity Ratio of 0.08 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-38.09 %-38.09%negative

Return on Equity(ROE) for the last financial year was -38.09%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding3.81 %0%neutral

Mutual Fund Holding remained the same in the last quarter at 3.81%.

Promoter Share Holding98.49 %0.29%positive

Promoter Share Holding increased by 0.29% in the most recent quarter to 98.49%.

Interest Coverage Ratio-324.17-negative

Interest Coverage Ratio is -324.17, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding4.95 %0%neutral

Institutional Holding remained the same in the last quarter at 4.95%.

VIEW LESS


Loading data..

Precipio Inc - Company Profile

What does Precipio Inc do?

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Precipio Inc Management structure

All Gross Remunerations are in USD
Mr. Ilan Danieli
Director and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Ahmed Zaki Sabet
Chief Operating Officer
-
2024
Gross Remuneration
Year
Dr. Ayman A. Mohamed
Chief Technology Officer
-
2024
Gross Remuneration
Year
Mr. Matthew Gage
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year

Precipio Inc Board of directors

All Gross Remunerations are in USD
Dr. Douglas Fisher, M.D.
Independent Director
-
2024
Gross Remuneration
Year
Ms. Christina Valauri
Independent Director
-
2024
Gross Remuneration
Year
Ms. Kathleen D. Laporte
Independent Director
-
2024
Gross Remuneration
Year
Mr. Richard A. Sandberg
Chairman of the Board
-
2024
Gross Remuneration
Year
Mr. Ronald A. Andrews, Jr
Independent Director
-
2024
Gross Remuneration
Year
Mr. Ilan Danieli
Director and Chief Executive Officer
-
2024
Gross Remuneration
Year

Precipio Inc FAQ

How is Precipio Inc today?
Precipio Inc today is trading in the green, and is up by 7.79% at 6.09.
Precipio Inc is currently trading up 7.79% on an intraday basis. In the past week the stock fell -10.04%. stock has been up 9.93% in the past quarter and fell -10.96% in the past year. You can view this in the overview section.